Lytix Biopharma ASA Stock: price and insider trades · Norway
No insider purchase over the last 90 days. The latest, by Chief Executive, was filed 11 Dec 2025.
Lytix Biopharma ASA: what insiders have been doing
Lytix Biopharma ASA belongs to the Healthcare & Pharma sector. Filings by its managers are published through Oslo Børs. Over the twelve months to 23 October 2026, 6 filings were filed, from 5 insiders.
No insider sold shares on the market over the period. Instead, the filings list 1 purchase totalling €8,470, made by 1 insider. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Biggest ticket of the year: €8,470, bought by Chief Executive and made public on 11 December 2025.
Compared with its exchange (257 companies, median 4 filings), a count of 6 filings is above the norm. Looking back to 2022, when coverage begins, insiders filed 4 purchases and no sales.
The clock since the last published purchase (11 December 2025) now reads 332 days.
Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and EssilorLuxottica. These figures are compiled from regulatory filings published by Oslo Børs. They describe what insiders did and are not a recommendation.
Who traded when
BuySaleSince the insiders bought
- -19.7%Entry NOK 9.84 · Close 21 Oct 2026 NOK 7.90
- -1.1%Entry NOK 9.40 · Close at T+365 NOK 9.30
- +14.3%Entry NOK 8.40 · Close at T+365 NOK 9.60
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Financial data
as of FY 2025FY ended December 2025 · cache
- OptionMERKOSLO:681627
- 12,000 shares@ NOK 8.30190.015% mcap100.0% of flowShareMERKOSLO:681499
- OptionMERKOSLO:678616
- OptionMERKOSLO:670327
- ShareMERKOSLO:663387
- 10,000 shares@ NOK 9.9984100.0% of flowShareMERKOSLO:661716Canonical exit: 11 Mar 2026 (T+90)
- OptionMERKOSLO:654449
- OptionMERKOSLO:647082
- ShareMERKOSLO:635698
- ShareMERKOSLO:634985
- ShareMERKOSLO:634909
- @ €0.0085ShareMERKOSLO:617032
- 724,448 shares@ NOK 5.24100.0% of flowShareMERKOSLO:616907
- OptionMERKOSLO:587883
- OptionMERKOSLO:578216
- 33,519 shares@ NOK 8.565621.7% of flowShareMERKOSLO:570389Canonical exit: 30 Nov 2022 (T+90)
- 125,000 shares@ NOK 7.971478.3% of flowShareMERKOSLO:569902Canonical exit: 25 Nov 2022 (T+90)
- 13,000 shares@ NOK 7.7274100.0% of flowShareMERKOSLO:569869Canonical exit: 24 Nov 2022 (T+90)
18 of 18 declarations
About Lytix Biopharma ASA
Lytix Biopharma ASA is a biopharmaceutical company focused on developing immuno-oncology treatments. It is listed on the XOSL market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations